Drugs / Autologous DC Therapy
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT04157127 | Aug 2020 → Jun 2026 overdue | pancreatic adenocarcinoma, pancreatic adenosquamous carcinoma | Diakonos Oncology Corporation | Recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Autologous DC Therapy | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04157127 ↗ |
| Route | Other | “administered by image-guided injections proximal to a lymph node near the surgical bed” NCT04157127 ↗ |